Presented at the ADA 85th Scientific Sessions: In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintidesemaglutide resulted in a significantly lower body weight than Tirzepatide 10mg Research Peptide Canada Durham Peptides Full article: Pharmacotherapy for Obesity: Recent Updates When do we choose semaglotide and when does terzipatide? EASO has just announced that it will update its algorithm with evidence until November 2025 Warning: It depends on the clinical goal.